TNF and Alzheimer disease: Therefore, other aspects to consider for future therapeutic approaches will also include tailoring TNF-α inhibition strategies based on individual patient profiles and genetic factors and finally the evaluation of the long-term safety and efficacy of these drugs in a peculiar population such as AD patients.